Navigation Links
Case Report Suggests Microbiome Therapeutics' NM504 May Improve Tolerability of Metformin While Improving Blood Glucose Control
Date:9/11/2013

BROOMFIELD, Colo., Sept. 11, 2013 /PRNewswire/ -- MicroBiome Therapeutics LLC, (MBT), a biotechnology company developing pharmaceutical and medical food products that shift the human microbiome in specific ways for improved health, today reported publication of a case report suggesting a potentially important new application for its lead product, NM504.  NM504 is in clinical development to promote healthy blood glucose levels and metabolic fitness in prediabetic and diabetic populations.

In the case report1, currently available in the online edition of Beneficial Microbes, researchers describe how co-administration of NM504 eliminated the dose-limiting diarrhea caused by metformin in a patient with newly-diagnosed type 2 diabetes.  Metformin, a safe, effective and inexpensive medication favoring weight loss, is the most widely prescribed diabetes drug worldwide, and it is recommended for initial treatment of type 2 diabetes by the American Diabetes Association. However, diarrhea is a well-known side effect of metformin therapy, affecting an estimated 20% of patients.  Physicians report diarrhea as a frequent cause of metformin discontinuation or dosage limitation. The second-line therapies prescribed in these cases as a substitute for metformin are expensive and carry risks of potentially serious side effects.

"NM504 virtually eliminated the diarrhea caused by metformin in this patient with type 2 diabetes and was also associated with additional large decreases in his highly elevated blood glucose levels," commented Mark Heiman, Ph.D., a co-author of the case report and chief scientific officer of MicroBiome Therapeutics.

Dr. Heiman continued, "Research shows that the human GI microbiome plays an important role in the regulation of metabolic processes, including changes as
'/>"/>

SOURCE MicroBiome Therapeutics LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. MarketPublishers.com Added New Report on L-(-)-Carnitine HCl (CAS 6645-46-1) Market to Its Catalogue
2. MarketPublishers.com Added New Report on 1,2 Hexanediol (CAS 6920-22-5) Market to Its Catalogue
3. New Reporting Guidelines For Case Reports Presented At The Congress On Peer Review And Biomedical Publication And Published In Seven Medical Journals
4. US Bioactive Wound Care Market 2016: Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2012-2016, Report Available Online by Researchmoz.us
5. MarketPublishers.com Added New Report on Coconut Oil (CAS 8001-31-8) Market to Its Catalogue
6. MarketPublishers.com Added New Report on STRONTIUM ALUMINATE (CAS 12004-37-4) Market to Its Catalogue
7. MarketPublishers.com Added New Report on Hexamine (CAS 100-97-0) Market to Its Catalogue
8. Global Biopesticides Market 2012-2016: Worldwide Industry Latest Market Share, Strategy, Growth, Size, Trends and Forecast Research Report 2016
9. MarketPublishers.com Added New Report on HUMIC ACID (CAS 1415-93-6) Market to Its Catalogue
10. Legislative Benefits and Unmet Needs to Drive the Market for Orphan Drugs, According to a New Report by Global Industry Analysts, Inc.
11. MarketPublishers.com Added New Report on Anhydrous Hydrofluoric Acid (CAS 7664-39-3) Market to Its Catalogue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... What: , Cambridge Semantics, the leading provider of ... today announced its participation in the 2014 Big Data ... solutions provide semantic linkage and meaning to Big Data ... manage diverse data. Ben Szekely, vice president and founding ... “life sciences data lake” and an approach for collecting ...
(Date:10/1/2014)... Greifensee, Switzerland (PRWEB) October 01, 2014 ... influence the quality of the final product. However, ... most regulated, regulatory frameworks such as Good Manufacturing ... is the responsibility of the manufacturer to interpret ... ensure consistent weighing performance quality. METTLER TOLEDO experts ...
(Date:10/1/2014)... 30, 2014 The participants committed to ... to spending their own time adjusting, tweaking and testing ... designs were ready for judging. , “I enjoyed being ... thought leader. “The entries showed a commendable range ... characteristics of the print medium and the creativity of ...
(Date:10/1/2014)... Award winning unified communications (UC) ... new-hosted collaboration bundles that combine next generation communication ... experiences for low, flat rate fees. With ... have optimized solutions to meet their technology needs. ... only minutes (1K, 5K, 10K increments) or audio ...
Breaking Biology Technology:Cambridge Semantics to Present ‘A Useful Approach to Big Data’ at 2014 Big Data Leaders Forum 2Comply with Weighing-Related Regulations in Pharma Manufacturing 2Array Architects Challenges Staff to Create with 3D Printer 2SoundConnect Launches New Audio, Web and Video Bundles 2
... Oct. 16 Compendia Bioscience, Inc.,today announced ... Premium Edition, a high-value product extension of ... Oncomine Research,Premium Edition includes custom gene filters, ... support for Oncomine Concepts Map,including the ability ...
... DRRX ) announced today that it will be hosting ... at 12:00 p.m. Eastern Time. A live audio,webcast of ... and will,be available by accessing DURECT,s homepage at ... to participate during the,live webcast, the call will be ...
... will receive milestones and ... by Altair - Altair to conduct clinical development ... FRANCISCO, Oct. 16 ,Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) ... Inc., a new venture,capital-funded biotechnology company, has been created to ...
Cached Biology Technology:Compendia Bioscience Announces the Release and Availability of Oncomine(TM) Research Premium Edition 2Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 2Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 3Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 4Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 5
(Date:10/2/2014)... 2014 CARTES ... identification and mobility which is being held at ... 6 November 2014, is proud to announce the ... agency FABERNOVEL.        (Logo: http://photos.prnewswire.com/prnh/20140526/689195) ... to support innovative businesses from the digital security ...
(Date:10/2/2014)... 2014 CARTES SECURE CONNEXIONS 2014 Conference: ... Sector CARTES SECURE CONNEXIONS 2014 is being held ... 6 November 2014. This 29 th  international meeting for ... mobility, will bring together the global community of a ... programme of conferences will set the pace for the ...
(Date:10/1/2014)... inheritance, showing for the first time that offspring can ... at least., This confronting idea, known as telegony, dates ... the early 20th Century with the advent of genetics., ... Crean, Professor Russell Bonduriansky and Dr Anna Kopps manipulated ... They found that the size of the young was ...
Breaking Biology News(10 mins):CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 2CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 3CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 4CARTES SECURE CONNEXIONS 2014 Launches the "Startup Challenge" to Support the Future Champions of Innovation 5CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 2CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 3CARTES SECURE CONNEXIONS - Conferences & Speakers 2014 4Semen secrets: How a previous sexual partner can influence another male's offspring 2
... multiple languages, cultures, races and religions, but among this diversity ... more united through our ears. In fact Mihailo Antovic, ... proposes that our musical conceptualization brings together a world of ... of distinct ethnic backgrounds and languages in his home of ...
... registration and abstract submission is now open at ... to be held in the Middle-East and Africa region. ... part of a new series of ,IOF Regionals, around ... energize research efforts in the region while offering advanced ...
... A drug already approved for people with cancer ... form of dementia, UT Southwestern Medical Center researchers report. ... a first-generation drug for the prevention and treatment of ... for which there is no treatment," said Dr. Joachim ...
Cached Biology News:1 world, 1 sound 21 world, 1 sound 3Cancer drug holds promise as first treatment for common, inherited dementia 2